InvestorsHub Logo
icon url

FUNMAN

08/05/20 9:57 AM

#13977 RE: john1311 #13976

Thanks 'john1311'. Aphria doesn't operate in a bubble. A little competitor perspective adds sanity to the announcement.

How about this: 20,000 patients compares to another little LP I own (Aleafia 49¢). They stated in their last ER they had more than 12,000 registered repeat patients (in their Canabo Medical Clinics).

And how about this too: If over 12 years Canndoc provided more than 750,000 doses, that's 62,500 per year, or 1,202 per week. Does that really sound significant?

So the deal is good because it adds another customer and country. One more brick in the wall.

It's not part of a grand LP acquisition strategy. Aphria has more cultivation capacity than they need. They were smart enough to NOT have fully planted Aphria Diamond. It's the same reason they should only acquire ACB at a fire sale price.

Without more impairment charges, there should be smiles all the way around.

I will be satisfied to see Aphria hold a $6 PPS after the next ER.
icon url

GoSing

08/05/20 10:21 AM

#13979 RE: john1311 #13976

May I please see these DD's?